D2 lymphadenectomy

PROCEDURE4 trials

Sponsors

Affiliated Cancer Hospital & Institute of Guangzhou Medical University, National Cancer Center, Korea, University of Alexandria

Conditions

Advanced Gastric AdenocarcinomaGastric Cancer

Phase 3

Efficacy of HIPEC in the Treatment of Patients With Locally Advanced Gastric Cancer

Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityAdvanced Gastric Adenocarcinoma

Start: 2014-07-31End: 2019-07-31Target: 582Updated: 2014-09-15

Efficacy of HIPEC in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2

Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityGastric Cancer

Start: 2015-05-11End: 2022-01-31Target: 584Updated: 2017-10-31

Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer

National Cancer Center, KoreaGastric Cancer

Start: 2015-08-06End: 2021-12-31Target: 518Updated: 2020-03-03

Unknown Phase

Curative D2 vs D1 Lymphadenectomy in Operable Gastric Carcinoma

CompletedNCT04340440

University of AlexandriaGastric Cancer

Start: 2014-12-31End: 2020-02-29Updated: 2020-04-10

Related Papers

Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial

Journal of Clinical Oncology2023-10-31107 citations

PILGRIM: Phase III clinical trial in evaluating the role of hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer patients after radical gastrectomy with D2 lymphadenectomy(HIPEC-01).

Journal of Clinical Oncology2020-05-207 citations

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Cancer Patients with Peritoneal Metastasis (PM): Results of a Single-Center Experience and Register Study

Journal of the Korean Gastric Cancer Association2018-01-0174 citations